Skip to content

Delivering precision pathology for 21st century medicine

We provide high quality and timely specialist technical services to researchers and academics, other healthcare providers and industry.

 

We operate as an innovation hub for tissue-based diagnostics including the development of novel prognostication tools and computational pathology.

Tissue Based Diagnostic & Research Services

Innovation

Collaboration

Seminar Workshop - Dr Max Robinson, Consultant Cellular Pathologist

Seminar Workshop - Colin Tristram, HistoCyte Laboratories Ltd

Seminar Workshop - Dr Darren Treanor, Consultant Pathologist & Director, National Pathology Imaging Co-operative

New Melanoma Referral Service from AMLo Biosciences

Professor Alastair David Burt

NovoPath was established in 2015 with funding from the MRC and EPSRC, one of six that were supported at that time. In taking on the Directorship in early 2020, I see us having entered the next phase of our development, embracing recent developments in tissue-based diagnostics and exploring new methodologies including virtual staining. We are working towards a digital future while also developing the next generation of precision pathologists

Key people

Professor Alastair Burt

 Director of NovoPath - Newcastle MRC Node

Dr Chris Bacon

 Deputy Director

Dr Max Robinson

 Deputy Director

Dr Chris Carey

 Deputy Director

Dr Chris Kettle

 Operational Manager

Claire Jones

 Advanced Biomedical Scientist

Sarah Leigh Nicholson

 Cellular Pathology Laboratory Manager
More

Collaboration

NovoPath is a key component of Diagnostics and Therapeutics North East (DxNE/TxNE) which was established to bring together and present a unique seamless infrastructure to life science organisations to support innovation, development and evaluation of new therapeutics and diagnostics for the NHS. DxNE/TxNE offers an unrivalled network from discovery science to clinical adoption, evaluation and horizon scanning.

Get involved

  • Leica Biosystems

    Kieran O’Toole, Principal Scientist

    NovoPath has provided Leica Biosystems with multiple core tissue microarray blocks designed to meet our specific requirements. The work has been carried out promptly and to a high standard.

  • Rarecan

    Andy Hall, Chief Scientific Officer

    Novopath has been instrumental in supporting RareCan by using their expertise and specialist facilities to obtain and process samples from patients throughout the UK with rare forms of cancer for genetic analysis.

Home

NovoPath
NovoPath
Cellular Pathology
Royal Victoria Infirmary
Queen Victoria Road
Newcastle upon Tyne
NE1 4LP

Tel: +44(0)1912824460
Email: nuth.novopath@nhs.net